[row][paragraph_left]
Upgrading your recombinant protein expression: Expert advice on optimizing mammalian cell–based production – Now Complimentary on Demand
In case you missed our live, online educational seminar, “Upgrading your recombinant protein expression: Expert advice on optimizing mammalian cell–based production” we wanted to let you know that it is available in our complimentary on-demand archive.
You can access this archive to watch the webinar at any time.
For more information and access to the archive, go to:
webinar.sciencemag.org
About This Webinar
The expression of recombinant proteins plays a pivotal role in the life sciences, with applications ranging from basic research to the production of biopharmaceuticals. Thus, it is critical to have an expression technology available that can provide suitable amounts of functional, high-quality recombinant protein in a reliable manner. In this webinar, our experts will discuss the key factors necessary for establishing and applying an efficient expression system based on Chinese hamster ovary (CHO) cells. Topics will include how to choose the best expression vector, host cell line, and selection system, as well as how to optimize the culture medium, growth conditions, and production process. Furthermore, we will highlight a variety of approaches to improve the productivity and reliability of CHO expression systems.
During the webinar, the speakers will:
• Introduce the most critical factors for achieving successful recombinant protein expression
• Offer advice on optimizing the most important variables for producing high-quality proteins at sufficient concentrations
• Highlight pitfalls and challenges in the production workflow, and how they can be overcome.
Participants:
Christoph Zehe, Ph.D.
Sartorius Stedim Cellca GmbH
Laupheim, GermanyBeate Stern, Ph.D.
UniTargetingResearch AS
Bergen, Norway
Register at:
webinar.sciencemag.org
Questions? E-mail: webinar@aaas.org.
Produced by the Science/AAAS Custom Publishing Office and sponsored by Sartorius Stedim Biotech.
[/paragraph_left][third_paragraph]
[/third_paragraph][/row]